|
NAV1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.51039999793679E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.17509999997267E-06 |
| Normal-vs-Stage2 |
2.063700E-02 |
| Normal-vs-Stage3 |
1.831190E-04 |
| Normal-vs-Stage4 |
7.204700E-04 |
| Stage1-vs-Stage2 |
3.791000E-01 |
| Stage1-vs-Stage3 |
7.178800E-01 |
| Stage1-vs-Stage4 |
3.294800E-01 |
| Stage2-vs-Stage3 |
2.836000E-01 |
| Stage2-vs-Stage4 |
1.404780E-01 |
| Stage3-vs-Stage4 |
5.234000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.9284999970034E-08 |
| Normal-vs-AfricanAmerican |
3.742000E-02 |
| Normal-vs-Asian |
8.445500E-02 |
| Caucasian-vs-AfricanAmerican |
4.514800E-01 |
| Caucasian-vs-Asian |
1.481990E-01 |
| AfricanAmerican-vs-Asian |
1.221400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.683800000014E-07 |
| Normal-vs-Female |
1.95899999999583E-05 |
| Male-vs-Female |
8.284600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.567780E-02 |
| Normal-vs-Age(41-60Yrs) |
9.32930000030474E-07 |
| Normal-vs-Age(61-80Yrs) |
4.88099999995661E-06 |
| Normal-vs-Age(81-100Yrs) |
5.385200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.977010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.553760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.748300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.902600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.356450E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.780190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.484170E-02 |
| Normal-vs-Grade 2 |
3.03030000003979E-06 |
| Normal-vs-Grade 3 |
3.829600E-04 |
| Normal-vs-Grade 4 |
9.63720000000112E-05 |
| Grade 1-vs-Grade 2 |
8.687900E-02 |
| Grade 1-vs-Grade 3 |
2.747600E-02 |
| Grade 1-vs-Grade 4 |
7.052400E-01 |
| Grade 2-vs-Grade 3 |
2.795400E-01 |
| Grade 2-vs-Grade 4 |
8.760500E-02 |
| Grade 3-vs-Grade 4 |
2.499900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.421100E-04 |
| Normal-vs-ccB subtype |
1.23880000035825E-07 |
| ccA subtype-vs-ccB subtype |
5.117500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.54850000003248E-06 |
| Normal-vs-N1 |
8.851800E-02 |
| N0-vs-N1 |
3.405200E-01 |
|
|
